Michael Arenberg

Verksamhetschef på IMAGO BIOSCIENCES, INC.

56 år

Health Technology

Consumer Services

Profil

Michael H.
Arenberg was the founder of IntraEAR, Inc. founded in 1996, where he held the title of VP-Sales, Marketing & Business Development from 1996 to 1999.
Currently, he is the Chief Operating & Business Officer at Imago BioSciences, Inc. since 2022.
Previously, he worked at DURECT Corp.
from 1999 to 2022, where he held the title of Senior VP-Corporate & Business Development from 2012 to 2018.
Mr. Arenberg has a graduate degree from the University of Denver and an MBA from Leavey School of Business.

Aktiva positioner av Michael Arenberg

Företag	Position	Start
IMAGO BIOSCIENCES, INC.	Verksamhetschef	2022-03-23

Alla aktiva positioner av Michael Arenberg

Tidigare kända positioner av Michael Arenberg

Företag	Position	Slut
DURECT	Finansdirektör/CFO	2022-03-17
IntraEAR, Inc. IntraEAR, Inc. Medical SpecialtiesHealth Technology Develops drug delivery devices for inner-ear maladies	Grundare	1999-01-01

Se detaljerna i Michael Arenbergs erfarenhet

Michael Arenbergs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Michael Arenbergs erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
DURECT Corp. DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases	Health Technology
IntraEAR, Inc. IntraEAR, Inc. Medical SpecialtiesHealth Technology Develops drug delivery devices for inner-ear maladies	Health Technology
University of Denver University of Denver Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Leavey School of Business Leavey School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Imago BioSciences, Inc. Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases	Health Technology